Genomic & Biopharma News

New findings support the routine use of remdesivir in hospitalized COVID-19 patients
Remdesivir, an antiviral drug used to treat COVID-19, increased the likelihood of clinical improvement in COVID-19 patients on low-flow oxygen or no oxygen, according to a new study authored by the Johns Hopkins University School of Medicine, the Johns Hopkins Bloomberg School of Public Health, HCA Healthcare, and Genospace.
News Medical Life Sciences, 2022-01-18 22:50:08

Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach

ORB Company News, 2016-12-02 21:24:27

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy
In a preliminary study of 106 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers report that as many as a third of those with the blinding retinal disease may someday be able to safely stop eye injection therapy without further vision loss.
News Medical Life Sciences, 2022-01-18 22:40:33

NIH launches first phase of $9.8 million competition to accelerate development of neuromodulation therapies
The Neuromod Prize seeks targeted treatments that adjust nerve activity to improve organ function.
National Institutes of Health, 2022-01-18 22:15:00

Study finds COVID booster maintains strong T cell response against Omicron
New study results posted to the medRxiv* preprint server found that COVID vaccine boosters increase immunity by enhancing T cell immune memory. In the face of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant, vaccinated people who had received a third booster shot maintained high T cell responses than people with naturally acquired immunity or vaccine-induced immunity from two doses of the SARS‑CoV‑2 vaccine.
News Medical Life Sciences, 2022-01-18 21:51:00

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy
A recent article published in the journal Science explains how SARS-CoV-2 variants can bypass vaccine-induced immune defenses. However, immunity is restorable with a booster shot. The paper's authors outlined the importance of a booster shot in maintaining immunity and preventing severe infection.
News Medical Life Sciences, 2022-01-18 21:31:00

SARS-CoV-2 may cause fetal inflammation even in the absence of placental infection
Small NIH study contributes to understanding of COVID-19 during pregnancy.
National Institutes of Health, 2022-01-18 21:00:00

Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach

ORB Company News, 2016-12-02 21:24:27

Survival rate increases for extremely preterm infants in NIH-funded research network
Study includes more than 10,000 infants born at 22 to 28 weeks of pregnancy.
National Institutes of Health, 2022-01-18 21:00:00

"Nocebo" Effect May Cause Majority of COVID-19 Vaccine Symptoms
A negative version of the placebo effect may be behind many instances of mild side effects associated with the jabs, a study suggests.
The Scientist, 2022-01-18 20:57:30

Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction
The study was conducted in two rural Massachusetts jails.
National Institutes of Health, 2022-01-18 19:00:00